Rep. Rick Larsen discloses trade(s) in ABT, APH, MCK, SPGI
Rick Larsen (WA02) disclosed 4 transactions, traded Jul 8: 2 purchases and 2 sales.
| Traded | Ticker | Company | Action | Amount | Owner |
|---|---|---|---|---|---|
| Jul 8 | ABT | Abbott Laboratories | Sell | $1,001 - $15,000 | Self |
| Jul 8 | APH | Part of advisor-driven quarterly rebalancing Amphenol Corporation | Buy | $1,001 - $15,000 | Self |
| Jul 8 | MCK | Part of advisor-driven quarterly rebalancing McKesson Corporation | Buy | $1,001 - $15,000 | Self |
| Jul 8 | SPGI | Part of advisor-driven quarterly rebalancing S&P Global Inc. | Sell | $1,001 - $15,000 | Self |
ORIGINAL FILING ↗ALL FILINGS BY RICK LARSEN →CONGRESS TRADES DASHBOARD →
Amounts are the ranges members report. Rows are read automatically from the filing; a trade split across a page break can be missed, so the original filing is the full record.
What This Means
A U.S. House member has filed financial disclosures showing transactions in four large-cap stocks spanning healthcare, industrial components, pharmaceuticals distribution, and financial services. Congressional stock trading disclosures are public record and tracked by markets observers for potential conflicts of interest or signals of legislative intent, though individual trades by members do not typically move markets on their own.
Sources — 1 tier
Every claim below links directly to the original reporting it was drawn from. Penblock synthesizes and cross-references these sources — it doesn't originate the reporting.
- Hon. Rick LarsenSep 29, 2026Rep. Rick Larsen discloses trade(s) in ABT, APH, MCK, SPGI ↗
How This Could Play Out — recorded when first flagged, not updated
Resolve
UNLIKELYA formal investigation or enforcement action finding no violation would likely have minimal direct market impact on the four stocks, as the disclosure itself already satisfies transparency requirements and routine rebalancing typically carries no systemic implications.
Left Unattended
LIKELYThese trades remain routine congressional disclosures with no follow-up scrutiny or media amplification, leaving the four stocks unaffected by any legislative or reputational pressure tied to the transaction.
Escalate
POSSIBLEIf media or watchdog groups flag the timing or pattern of these trades as suspicious relative to committee work or legislative activity, heightened scrutiny could create temporary reputational headwinds for the affected stocks or broader pressure on congressional trading norms, though the magnitude would depend on the severity of alleged impropriety.
SPONSORED
Confidence History
- HIGH CONFIDENCESep 29, 2026 at 6:04 PM
Legally mandated financial disclosure filing -- primary source, not a report about the event